Stalevo 50

Carbidopa + Entacapone + Levodopa

Carbidopa/levodopa/entacapone, sold under the brand name Stalevo among others, is a dopaminergic fixed-dose combination medication that contains carbidopa, levodopa, and entacapone for the treatment of Parkinson's disease.[3] It is marketed by Swiss-based Novartis Pharmaceuticals and manufactured by Finnish drugmaker Orion Corporation.[3] Contents 1 Medical uses 2 Side effects 2.1 Prostate cancer 2.2 Cardiovascular risks 3 Drug interactions 4 Mechanism of ...

NDC Database

Stalevo 50 Oral Tablet by Novartis Pharmaceuticals Corporation ## Markings: LCE;50 ## Shape: Round ## Color: Brown ## Package Codes: 0078-0407-05, 0078-0407-28 ## Active Ingredients: Carbidopa + Entacapone + Levodopa

NDC Database

Stalevo 200 (Carbidopa 50 mg / Entacapone 200 mg / Levodopa 200 mg) Oral Tablet by Novartis Pharmaceuticals Corporation ## Markings: LCE;200 ## Shape: Oval ## Color: Brown ## Package Codes: 0078-0527-05 ## Active Ingredients: Carbidopa + Entacapone + Levodopa